Trials / Completed
CompletedNCT03218436
Physical Cold Atmospheric Plasma for the Treatment of Cervical Intraepithelial Neoplasia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 63 (actual)
- Sponsor
- University Hospital Tuebingen · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Cervical intraepithelial neoplasia will be treated with physical low temperature plasma in the plasma cohort compared to watchful waiting in the control cohort. Primary endpoint after 3-6 months: Pathological remission. Secondary endpoint: HPV remission.
Detailed description
The study was completed with Less recruitment as it was planned due to overwhelming study success. The study was published in August 2023. A link has been added to the Reference section.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | CAP treatment | Treatment with low-temperature argon plasma during colposcopic examination. No general anesthesia required. |
Timeline
- Start date
- 2017-09-01
- Primary completion
- 2022-03-31
- Completion
- 2022-03-31
- First posted
- 2017-07-14
- Last updated
- 2024-07-23
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03218436. Inclusion in this directory is not an endorsement.